Clinical trial
Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian…
NCT00445887 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00445887 |
|---|---|
| Title | Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer |
| Official title | Phase II Double Blind Randomized Trial Evaluating the Biologic Effect of Levonorgestrel on the Double Blind Randomized Trial Evaluating the Biologic Effect of Levonorgestrel on the Ovarian Epithelium in Women at High Risk for Ovarian Cancer |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Carcinoma |
| Intervention type | Drug, Other |
| Interventions | Laboratory Biomarker Analysis, Levonorgestrel, Placebo |
| Enrollment | 60 |
| Start date | Mar 10, 2008 |
| Primary completion | Dec 11, 2013 |
| First posted | Mar 9, 2007 |
| Last update posted | Nov 19, 2019 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: